1. Hsu, Pei-Ling, Chien, Chun-Wei, Tang, Yen-An, Sun, H Sunny, Tsai, Shaw-Jenq. 2023. Targeting BRD3 eradicates nuclear TYRO3-induced colorectal cancer metastasis. In Science advances, 9, eade3422. doi:10.1126/sciadv.ade3422. https://pubmed.ncbi.nlm.nih.gov/37043564/
2. Hashimoto, Masahiro, Masuda, Takaaki, Nakano, Yusuke, Mori, Masaki, Mimori, Koshi. 2024. Tumor suppressive role of the epigenetic master regulator BRD3 in colorectal cancer. In Cancer science, 115, 1866-1880. doi:10.1111/cas.16129. https://pubmed.ncbi.nlm.nih.gov/38494600/
3. Seifritz, Tanja, Brunner, Matthias, Camarillo Retamosa, Eva, Ospelt, Caroline, Klein, Kerstin. 2023. BRD3 Regulates the Inflammatory and Stress Response in Rheumatoid Arthritis Synovial Fibroblasts. In Biomedicines, 11, . doi:10.3390/biomedicines11123188. https://pubmed.ncbi.nlm.nih.gov/38137409/
4. Lee, Jang Hyuck, Yoo, Seung Soo, Hong, Mi Jeong, Jheon, Sanghoon, Park, Jae Yong. 2021. Epigenetic readers and lung cancer: the rs2427964C>T variant of the bromodomain and extraterminal domain gene BRD3 is associated with poorer survival outcome in NSCLC. In Molecular oncology, 16, 750-763. doi:10.1002/1878-0261.13109. https://pubmed.ncbi.nlm.nih.gov/34605158/